Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Daunomycin derivative with reduced cytotoxicity toward normal cells

Daunomycin derivative with reduced cytotoxicity toward normal cells

US Patent 5413992 · Granted May 9, 1995

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Derivatives of thailanstatin A, methods of treatment and methods of synthesis th2023
Synthesis of disorazoles and analogs thereof as potent anticancer agents2022
Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugat2022
Total synthesis of trioxacarcin DC-45-A2 and preparation of trioxacarcin analogs2021
Derivatives of uncialamycin, methods of synthesis and their use as antitumor age2021
Epothilone analogs, methods of synthesis, methods of treatment, and drug conjuga2020
Preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolaricires2020
Desacetoxytubulysin H and analogs thereof2020
Total synthesis of shishijimicin A and analogs thereof2020
Process for making M1 receptor positive allosteric modulators2019
Process for making nucleoside phosphoramidate compounds2019
Derivatives of uncialamycin, methods of synthesis and their use as antitumor age2019